Michael Chopin is leading an innovative research program that investigates the transcriptional programming of the sentinels of the immune system: the Dendritic Cells (DCs). He graduated from Max Planck Institute for Molecular biology and Bioengineering (Dresden-Germany), and then joined the laboratory of Prof. Stephen Nutt at the Walter and Eliza Hall Institute as a post-doctoral fellow.  

Using state-of-the-arts genomics technologies, his postdoctoral studies have been essential to make new, impactful discoveries about cell fate decisions. These approaches include the generation of new conditional mouse mutagenesis models, genomic techniques, and novel cellular differentiation models for DCs; key innovations in the study of this fragile cell type.

In 2022, he established an independent research group at Monash University that is focusing on the molecular mechanisms underpinning DC differentiation and function.